The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory biomarker analysis of acelERA breast cancer (BC): Phase II study of giredestrant vs. physician’s choice of endocrine therapy (PCET) for previously treated, estrogen receptor-positive, HER2-negative advanced BC (ER+, HER2– aBC).
 
Ann Collier
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Mariana Chavez Mac Gregor
Employment - MD Anderson Physician’s Network
Consulting or Advisory Role - Abbott Laboratories; Adium Pharma; AstraZeneca; AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Exact Sciences; Exact Sciences; Exact Sciences; Lilly; Pfizer; Pfizer; Roche/Genentech
Research Funding - Genentech/Roche (Inst); Lilly; Novartis (Inst); Pfizer (Inst)
Expert Testimony - AstraZeneca; Genentech; Lilly; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Exact Sciences; Zodiac Pharma
(OPTIONAL) Uncompensated Relationships - Legacy Healthcare Services; The Hope Foundation
 
Stephanie Hilz
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Joohyuk Sohn
Stock and Other Ownership Interests - Daiichi Sankyo (I)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagan (Inst)
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; SEAGEN
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii-Sankyo
Other Relationship - Novartis; Roche
 
Elgene Lim
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Walter & Eliza Hall Institute of Medical Research (Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737)
Travel, Accommodations, Expenses - AstraZeneca; Lilly
 
Jorge Martinalbo
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Pablo Diego Pérez-Moreno
Employment - Genentech
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Heather M. Moore
Employment - Genentech; Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I); Roche
Research Funding - Roche